NO20076387L - Anvendelse av IL-18BP isoformer til behandling og/eller forhindring av neurologiske inflammatoriske sykdommer - Google Patents
Anvendelse av IL-18BP isoformer til behandling og/eller forhindring av neurologiske inflammatoriske sykdommerInfo
- Publication number
- NO20076387L NO20076387L NO20076387A NO20076387A NO20076387L NO 20076387 L NO20076387 L NO 20076387L NO 20076387 A NO20076387 A NO 20076387A NO 20076387 A NO20076387 A NO 20076387A NO 20076387 L NO20076387 L NO 20076387L
- Authority
- NO
- Norway
- Prior art keywords
- prevention
- treatment
- isoforms
- inflammatory diseases
- neurological inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SAMMENDRAG Oppfinnelsen angår anvendelse av en IL- I 813P-isoforrn som ikke bindes til IL- I 8 eller en agonist derav, til behandling eller forhindring av en nevrologisk og/eller inflammatorisk sykdom. Foretrukne isoformer for anvendelse innenfor rammen av den foreliggende oppfinnelsen inkluderer IL- I 8BPb og IL- I 8BPd.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05104863 | 2005-06-03 | ||
US68805705P | 2005-06-07 | 2005-06-07 | |
PCT/EP2006/062864 WO2006128911A2 (en) | 2005-06-03 | 2006-06-02 | Use of il-18bp isoforms for the treatment and/or prevention of neurological inflammatory diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20076387L true NO20076387L (no) | 2008-02-29 |
NO339540B1 NO339540B1 (no) | 2016-12-27 |
Family
ID=35058651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20076387A NO339540B1 (no) | 2005-06-03 | 2007-12-11 | Anvendelse av IL-18BP isoformer til behandling og/eller forhindring av neurologiske inflammatoriske sykdommer |
Country Status (17)
Country | Link |
---|---|
US (1) | US8128920B2 (no) |
EP (1) | EP1888100B1 (no) |
JP (1) | JP5048658B2 (no) |
AT (1) | ATE530227T1 (no) |
AU (1) | AU2006254106B2 (no) |
CA (1) | CA2610691C (no) |
CY (1) | CY1112128T1 (no) |
DK (1) | DK1888100T3 (no) |
ES (1) | ES2376534T3 (no) |
HR (1) | HRP20110788T1 (no) |
IL (1) | IL187839A (no) |
NO (1) | NO339540B1 (no) |
PL (1) | PL1888100T3 (no) |
PT (1) | PT1888100E (no) |
RS (1) | RS52192B (no) |
SI (1) | SI1888100T1 (no) |
WO (1) | WO2006128911A2 (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7968684B2 (en) | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030105057A1 (en) * | 1997-03-19 | 2003-06-05 | Yale University | Methods and compositions for stimulating apoptosis and cell death or for inhibiting cell growth and cell attachment |
IL121860A0 (en) | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
JP4216950B2 (ja) * | 1998-09-01 | 2009-01-28 | 株式会社林原生物化学研究所 | インターロイキン−18結合蛋白質 |
CA2340579A1 (en) | 1998-09-01 | 2000-03-09 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin 18-binding protein |
PE20011350A1 (es) * | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE) |
AU2002224417A1 (en) * | 2000-10-18 | 2002-04-29 | Immunex Corporation | Methods for treating il-18 mediated disorders |
KR20040030625A (ko) * | 2001-05-25 | 2004-04-09 | 아레스 트레이딩 에스.에이. | Cns 손상을 치료하거나 예방하기 위한 il-18저해물질의 용도 |
JP5074030B2 (ja) | 2003-05-13 | 2012-11-14 | メルク セローノ ソシエテ アノニム | Il−18結合タンパク質の活性変異体とその医学的応用 |
-
2006
- 2006-06-02 JP JP2008514119A patent/JP5048658B2/ja active Active
- 2006-06-02 DK DK06763485.7T patent/DK1888100T3/da active
- 2006-06-02 AU AU2006254106A patent/AU2006254106B2/en active Active
- 2006-06-02 WO PCT/EP2006/062864 patent/WO2006128911A2/en active Application Filing
- 2006-06-02 CA CA2610691A patent/CA2610691C/en active Active
- 2006-06-02 PL PL06763485T patent/PL1888100T3/pl unknown
- 2006-06-02 ES ES06763485T patent/ES2376534T3/es active Active
- 2006-06-02 AT AT06763485T patent/ATE530227T1/de active
- 2006-06-02 US US11/915,913 patent/US8128920B2/en active Active
- 2006-06-02 RS RS20120014A patent/RS52192B/en unknown
- 2006-06-02 PT PT06763485T patent/PT1888100E/pt unknown
- 2006-06-02 SI SI200631215T patent/SI1888100T1/sl unknown
- 2006-06-02 EP EP06763485A patent/EP1888100B1/en active Active
-
2007
- 2007-12-03 IL IL187839A patent/IL187839A/en active IP Right Grant
- 2007-12-11 NO NO20076387A patent/NO339540B1/no unknown
-
2011
- 2011-10-27 HR HR20110788T patent/HRP20110788T1/hr unknown
- 2011-11-30 CY CY20111101178T patent/CY1112128T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2610691C (en) | 2015-12-01 |
ES2376534T3 (es) | 2012-03-14 |
HRP20110788T1 (hr) | 2011-11-30 |
EP1888100B1 (en) | 2011-10-26 |
NO339540B1 (no) | 2016-12-27 |
CY1112128T1 (el) | 2015-11-04 |
PL1888100T3 (pl) | 2012-03-30 |
DK1888100T3 (da) | 2012-01-23 |
US8128920B2 (en) | 2012-03-06 |
IL187839A0 (en) | 2008-03-20 |
JP5048658B2 (ja) | 2012-10-17 |
US20080233085A1 (en) | 2008-09-25 |
AU2006254106B2 (en) | 2012-04-26 |
WO2006128911A2 (en) | 2006-12-07 |
JP2008542340A (ja) | 2008-11-27 |
WO2006128911A3 (en) | 2007-03-29 |
SI1888100T1 (sl) | 2012-01-31 |
AU2006254106A1 (en) | 2006-12-07 |
RS52192B (en) | 2012-10-31 |
CA2610691A1 (en) | 2006-12-07 |
PT1888100E (pt) | 2011-12-15 |
AU2006254106A8 (en) | 2008-04-03 |
IL187839A (en) | 2013-03-24 |
ATE530227T1 (de) | 2011-11-15 |
EP1888100A2 (en) | 2008-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065984L (no) | Forbindelser og sammensetninger som PPAR modulatorer | |
MX2007009356A (es) | Compuestos y composiciones como moduladores de ppar. | |
NL301089I2 (nl) | imlifidase | |
TW200630096A (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
NO20065983L (no) | Forbindelser og sammensetninger som PPAR modulatorer | |
EA200900828A1 (ru) | Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 | |
JP2009519986A5 (no) | ||
TW200602330A (en) | Compounds and compositions as PPAR modulators | |
NO20082699L (no) | Immunoglobuliner | |
NO20054913L (no) | Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser | |
IL180979A (en) | Isoindulin compounds and their use | |
ATE445624T1 (de) | Verbindungen und zusammensetzungen als ppar- modulatoren | |
TW200611695A (en) | Pyrrolopyridine derivatives | |
WO2007056366A3 (en) | Compounds and compositions as ppar modulators | |
MX2008012400A (es) | Azolopirimidinas como inhibidores de actividad de cannabinoide 1. | |
HK1092467A1 (en) | N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n- | |
EA200801244A1 (ru) | Применение sdf-1 для лечения и/или профилактики неврологических заболеваний | |
TW200745081A (en) | Compounds | |
CY1113310T1 (el) | Εξανθρωπισμενα αντισωματα ειδικα για nogo-a και φαρμακευτικες χρησεις αυτων | |
EA200701867A1 (ru) | Хинолиноновые соединения в качестве агонистов рецептора 5-ht | |
NO20076387L (no) | Anvendelse av IL-18BP isoformer til behandling og/eller forhindring av neurologiske inflammatoriske sykdommer | |
TNSN06381A1 (en) | Compounds and compositions as ppar modulators | |
TW200734335A (en) | Compounds | |
WO2007022938A3 (en) | Compounds | |
ATE397755T1 (de) | Diagnostik- und therapie- verfahren von mit dopaminrezeptor d3 (drd3) verbundenen krankheiten |